---
name: GenoSafe
slug: genosafe
site: cro
website_domain: genosafe.com
summary: GenoSafe is an analytical CRO for gene and cell therapies, innovative vaccines and DNA/RNA-based products. It offers preclinical analytical testing, quality control method development for ATMPs, and clinical sample bioanalysis. Headquartered in Evry-Courcouronnes, France.
tagline: Analytical CRO for innovative therapies
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: FR
tier2_domain_verified: false
updated_at: 2026-10-20T07:01:20.633Z
services_count: 3
modalities_count: 3
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# GenoSafe

Analytical CRO for innovative therapies

Listed on cro.directory.

## Summary

GenoSafe is an analytical CRO for gene and cell therapies, innovative vaccines and DNA/RNA-based products. It offers preclinical analytical testing, quality control method development for ATMPs, and clinical sample bioanalysis. Headquartered in Evry-Courcouronnes, France.

## At a glance

- HQ country: FR

## Services

- Analytical Method Development & Validation
- Quality Control Testing
- Bioanalysis

## Modalities

- Gene Therapy
- Cell Therapy
- Vaccine

## Locations

- Evry-Courcouronnes, Evry-Courcouronnes, France

## Long description

GenoSafe is a contract research organization focused on the characterization and evaluation of innovative therapeutics. The company supports sponsors across research, preclinical studies, quality control, and clinical studies.

## Fields of activity

- **Preclinical development:** Development and validation of analytical methods, and analysis of samples for research or regulatory toxicity studies.
- **Quality control:** Development, qualification and validation of methods to evaluate the quality, safety and efficacy of Advanced Therapy Medicinal Products (ATMPs).
- **Clinical development:** Development, qualification and validation of methods for clinical sample analysis.

## Scope

GenoSafe focuses on innovative therapeutics, including gene and cell therapies, innovative vaccines, and DNA/RNA-based products. The company states that its services are designed to comply with regulatory standards applicable to each aspect of pharmaceutical development.

## Teams and labs

The company describes its teams and platforms as providing the expertise and quality needed for analytical work, with a dedicated contact assigned to each project.

## Related companies

- [SGVector](/companies/sgvector) (Analytical Method Development & Validation, Gene Therapy) — [Compare](/compare/genosafe/sgvector)
- [ProBio](/companies/probio) (Analytical Method Development & Validation, Bioanalysis) — [Compare](/compare/genosafe/probio)
- [Emery Pharma](/companies/emerypharma) (Analytical Method Development & Validation, Bioanalysis) — [Compare](/compare/emerypharma/genosafe)
- [StemExpress](/companies/stemexpress) (Gene Therapy, Cell Therapy) — [Compare](/compare/genosafe/stemexpress)
- [Solvias](/companies/solvias) (Analytical Method Development & Validation, Quality Control Testing) — [Compare](/compare/genosafe/solvias)
- [PrimeVigilance](/companies/primevigilance) (Gene Therapy, Cell Therapy) — [Compare](/compare/genosafe/primevigilance)
- [Intrepid Labs](/companies/intrepid-labs) (Analytical Method Development & Validation) — [Compare](/compare/genosafe/intrepid-labs)
- [Resolian](/companies/resolian) (Analytical Method Development & Validation, Bioanalysis) — [Compare](/compare/genosafe/resolian)

_Profile last updated: 2026-10-20T07:01:20.633Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.